Latest News
- Professor emerita honored for mentoring trainees, colleagues
Judith Gasson has been awarded the 2020 American Society of Hematology Basic Science Mentor Award for her contributions to mentoring numerous hematology trainees throughout her career.
July 02, 2020 8:00 AM
detail - Dr. Vatche Agopian named Director of the Dumont-UCLA Liver Cancer Center
The UCLA Jonsson Comprehensive Cancer Center is proud to announce that Dr. Vatche Agopian, Associate Program Director for the General Surgery training program, has been appointed Director of the Dumont-UCLA Liver Cancer Center.
July 01, 2020 1:00 PM
detail - UCLA researchers find cryotherapy as an effective treatment for men with intermediate-risk prostate cancer
UCLA researchers have found that hemi-gland cryoablation, or cryotherapy, is an effective, primary treatment for men with clinically-significant, or grade 2, prostate cancer.
July 01, 2020 9:00 AM
detail - Cancer association recognizes three scientists for advancing research
Three researchers from the UCLA Jonsson Comprehensive Cancer Center are part of the newest class of the American Association for Cancer Research grant and award recipients for dedicating their careers to advancing the detection, prevention, and treatment of cancer.
June 30, 2020 9:00 AM
detail - Dr. Antoni Ribas: portrait of a physician-scientist
Watch this video to learn more about Dr. Ribas and for an intimate portrait of one of UCLA Health's leading physician-scientists.
June 18, 2020 10:00 AM
detail - UCLA receives nearly $14 million from NIH to investigate gene therapy to combat HIV
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group — known as Gleason grade group 5 — and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.
June 18, 2020 8:00 AM
detail - Researcher receives grant to study new immunotherapy treatment for deadly skin cancer
Dr. Anusha Kalbasi is one of four recipients to be named a 2020 Damon Runyon Clinical Investigator by the Damon Runyon Cancer Research Foundation.
June 17, 2020 8:00 AM
detail - Q&A with UCLA’s Antoni Ribas on what to expect at AACR’s virtual meeting
In this Q&A, AACR President Antoni Riba shares how his role of President of AACR is evolving and what to expect at the second part of the virtual meeting.
June 16, 2020 12:00 PM
detail - Some types of prostate cancer may not be as aggressive as originally thought
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group — known as Gleason grade group 5 — and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.
June 04, 2020 9:00 AM
detail - Q&A: FDA approves new first-line treatment for patients with metastatic EGFR-mutated non-small cell lung cancer
Dr. Edward Garon breaks down the significance of the FDA approval and it what it means for patients diagnosed with this type of lung cancer.
June 04, 2020 8:00 AM
detail - FDA approves immunotherapy drug combination for people with most common type of liver cancer
For the first time in over a decade, a new drug combination has been approved by the U.S. Food & Drug Administration to treat hepatocellular carcinoma as a first-line treatment.
May 29, 2020 1:30 PM
detail - New drug combinations help overcome resistance to immunotherapy
A new study from UCLA researchers helps explain how disruptions in genes can lead to the resistance to one of the leading immunotherapies, PD-1 blockade.
May 28, 2020 7:00 AM
detail - $5.75M grant to help researchers study role of obesity in development of pancreatic cancer
A team of researchers from UCLA and peer institutions has been awarded a $5.75 million grant from the National Cancer Institute to study the correlation between obesity, inflammation and pancreatic cancer.
May 20, 2020 10:30 AM
detail - UCLA scientists alter genes of innate immune cells with DNA-snipping tool
A UCLA research team has successfully used the powerful gene-editing tool known as CRISPR-Cas9 to alter the DNA of mature innate immune cells, some of the body’s first responders to infections.
May 20, 2020 9:00 AM
detail - UCLA launches clinical trial to help reduce severity of COVID-19 illness in men
UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19.
May 15, 2020 12:00 PM
detail - UCLA researchers to present on latest advancements in cancer therapies at annual ASCO meeting
Physicians and scientists from UCLA’s Jonsson Comprehensive Cancer Center will be joining more than 32,000 scientists, clinicians, advocates and industry luminaries from institutions around the world to discuss the most recent advancements in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting.
May 15, 2020 8:00 AM
detail - New treatment extends lives of people with most common type of liver cancer
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
May 13, 2020 2:00 PM
detail - Immunotherapy pioneer named AACR Academy Fellow
Dr. Antoni Ribas has been inducted into the AACR's 2020 class of Fellows for his pioneering work in immunology.
May 13, 2020 8:00 AM
detail - Continuing your breast cancer care during COVID-19
Oncologist Sara Hurvitz helps answer common questions about how to safely continue your cancer care during the COVID-19 crisis.
May 08, 2020 4:00 PM
detail - FDA approves new drug for advanced lung cancer, first agent specific for patients with MET gene abnormalities
The U.S. Food & Drug Administration has approved capmatinib to treat patients with a type of advanced lung cancer that tends to have a poor prognosis.
May 07, 2020 8:00 AM
detail